Picture of Yidu Tech logo

2158 — Yidu Tech News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Yidu Tech Says Successful Bidding Of Phase I Clinical Trial From China Resources

Oct 26 (Reuters) - Yidu Tech Inc  2158.HK :
    * SUCCESSFUL BIDDING OF PHASE I CLINICAL TRIAL FROM CHINA
RESOURCES
    * BID FOR RMB13.7 MILLION
    * BID FOR PHASE I CLINICAL TRIAL OF SAFETY, TOLERABILITY OF
A
SINGLE DOSE OF CRB4101 IN HEALTHY ADULT SUBJECTS

Further company coverage:  2158.HK 
 ((reuters.briefs@thomsonreuters.com;))

Recent news on Yidu Tech

See all news